Jeffrey M. Leiden
2011 - Vertex Pharmaceuticals
In 2011, Jeffrey M. Leiden earned a total compensation of $10.7M as Chairman, President & CEO at Vertex Pharmaceuticals.
Compensation breakdown
| Option Awards | $7,077,542 |
|---|---|
| Salary | $50,000 |
| Stock Awards | $3,497,678 |
| Other | $92,441 |
| Total | $10,717,661 |
Leiden received $7.1M in option awards, accounting for 66% of the total pay in 2011.
Leiden also received $50K in salary, $3.5M in stock awards and $92.4K in other compensation.
Rankings
In 2011, Jeffrey M. Leiden's compensation ranked 318th out of 10,747 executives tracked by ExecPay. In other words, Leiden earned more than 97.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 318 out of 10,747 | 97th |
Division Manufacturing | 104 out of 3,960 | 97th |
Major group Chemicals And Allied Products | 23 out of 1,033 | 98th |
Industry group Drugs | 13 out of 781 | 98th |
Industry Pharmaceutical Preparations | 11 out of 571 | 98th |
Source: SEC filing on March 28, 2014.
Leiden's colleagues
We found four more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2011.